期刊文献+

酒石酸托特罗定和坦索罗辛治疗下尿路症状疗效分析 被引量:2

下载PDF
导出
摘要 目的评价对比和联合应用酒石酸托特罗辛和坦索罗辛缓解下尿路症状的疗效。方法筛选符合入组标准的患者分别联合应用酒石酸托特罗定和盐酸坦索罗辛6周,监测IPSS评分(包括总分、梗阻症状评分和刺激症状评分)、排尿日记(尿频次数、尿急发作次数、尿失禁次数、夜尿次数),比较各组治疗前后监测指标的差异。结果 联合用药能明显改善IPSS的总评分、尿急和夜尿增多的症状。酒石酸托特罗定对减少尿频次数、降低IPSS评分中的刺激症状更为有效。结论 酒石酸托特罗定和盐酸坦索罗辛联合应用对刺激症状为主的LUTS患者能产生更佳疗效。
作者 杨国联
出处 《中国现代医生》 2011年第16期81-82,共2页 China Modern Doctor
  • 相关文献

参考文献3

  • 1Irwin DE, Milsom I,Hunskaar S,et al.Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study[J]. Eur Urol,2006,50:1306-1315.
  • 2Abdel-Aziz KF,Lemack GE. Overactive bladder Jn the male patient:bladder, outlet, or both? [J]. Curr Urol Rep,2002,3:445-451.
  • 3Park CH, Chang HS, Oh BR,et al. Efficacy of low-dose tamsulosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia:a nonblind multicentre korean study[J]. Clin Drug Investig, 2004,24:41--47.

同被引文献23

  • 1Kaplan SA. Re:long-term treatment and prognostic factors of alphal-blockers for lower urinary tract symptoms asso- ciated with benign prostatic hyperplasia:a pilot study comparing naftopidil and tamsulosin hydrochloride [J]. J Urol,2011,185(1) :227.
  • 2Kojima Y,Sasaki S, Imura M,et al. Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria:a prospective open-label long-term study using frequency-volume chart [J]. Neu- rourol Urodyn, 2012,31 ( 1 ) : 80-85.
  • 3Chapple CR. Pharmacotherapy for benign prostatic hyper- plasia-the potential for alpha 1-adrenoceptor subtype- specific blockade [J]. Br J Urol, 1998,81 (Suppl 1 ) : 34-47.
  • 4Chung MS, Lee SH, Park KK, et al. Comparative rapid on- set of efficacy between doxazosin gastrointestinal thera- peutic system and tamsulosin in patients with lower uri- nary tract symptoms from benign prostatic hyperplasia:a muhicentre,prospective,randomized study [J]. Int J Clin Pract,2011,65(11) : 1193-1199.
  • 5Gacci M, Vittori G,Tosi N, et al. A randomized, placebo- controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia [J]. J Sex Med,2012,9(6) : 1624-1653.
  • 6Perincbery N. Ing-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associ- ated with benign prostatic hyperplasia [J]. J Urol,2003, 170(2 Pt 1) :498-502.
  • 7Mohammadi -Fallah M, Hamedanchi S, Tayyebi -Azar A. Preventive effect of tamsulosin on postoperative urinary re- tention [J]. Korean J Urol,2012,53(6):419-423.
  • 8Djavan B,Dianat SS,Kazzazi A. Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia:clinical utility of dutasteride and tamsulosin [J]. Patient Relat Outcome Meas,2011,2:71-79.
  • 9Chapple CR,Wyndaele JJ,Nordling J,et al. Tamsulosin,the first prostate-selective alpha 1A-adrenoceptor antag- onist. A meta-analysis of two randomized, placebo-con- trolled, multicentre studies in patients with benign pro- static obstruction (symptomatic BPH). European Tamsu- losin Study Group [J]. Eur Urol, 1996,29(2) : 155-167.
  • 10Oelke M, Giuliano F, Mirone V, et al. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international,randomised,parallel,placebo -con- trolled clinical trial [J]. Eur Urol,2012,61(5):917-925.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部